Victorian Clinical Genetics Services (VCGS), the genetic testing arm of Murdoch Children’s Research Institute, has welcomed the news that it is one of the three national research institutes chosen to be part of the $20-million genetic screening project – Mackenzie’s Mission.

The Mackenzie’s Mission pilot program will screen 10,000 couples to see if they are carriers of a genetic condition that could be passed on to a child.

Want a career change - consider genetic counselling

It is one of the rarest jobs in Australia – with only 230 employed nationwide – but on Thursday 8 November genetic counselling will become a little better known when Genetic Counsellor Awareness Day 2018 is celebrated.

Victorian Clinical Genetic Services (VCGS), the not-for-profit genetic testing arm of Murdoch Children’s Research Institute, carries out tests for hundreds of genetic conditions impacting adults and children.

NEW! Tiered Clinical Exome Sequencing test options

Any clinical gene, any panel at cost effective pricing

Victorian Clinical Genetics Services (VCGS) is pleased to announce our expanded range of tiered Clinical Exome Sequencing test options.

As of October 8, 2018 our new range of tiered exome test options are available to support more cost effective diagnosis for patients. For targeted analysis of well-defined phenotypes, choose from customised or pre-curated small, medium or large gene lists.

MCRI has been announced as the only non-European site to receive a prestigious Horizon2020 grant.

The researchers, led by VCGS' Professor Ravi Savarirayan, will receive AUD$8.4million to investigate a new treatment for Schmid dysplasia, a rare genetic disease characterised by short-limbed dwarfism and a waddling gait due to abnormalities in the legs and hips.

The 2018 Newborn Bloodspot Screening Best Practice Forum, presented by the Department of Health and Human Services and supported by Victorian Clinical Genetics Services (VCGS), was held on Friday 22 June in Melbourne. The forum featured presentations from leading experts with a focus on best practice, timeliness, quality, and an update on the recently released Newborn Bloodspot Screening National Policy Framework.

prepair image

Victorian Clinical Genetics Services (VCGS) welcomes the $500M allocation to investment in genomic research as part of the federal budget 2018.

The first research project ‘Mackenzie’s Mission’ is a $20M trial into pre-conception genetic carrier screening for serious genetic conditions like cystic fibrosis, spinal muscular atrophy and fragile X syndrome.